Ring Therapeutics is pioneering a new class of targeted medicines that deliver more through its Vectorology™ platform, which utilizes commensal viruses to develop novel vector conjugate therapies for gene therapy
Ring Therapeutics is pioneering a new class of targeted medicines that deliver more through its Vectorology™ platform, which utilizes commensal viruses to develop novel vector conjugate therapies for gene therapy.